The Benefits and Drawbacks of Chest Radiographs for Tuberculosis Care

Tuberculosis (TB) is a highly infectious airborne disease that is caused by the bacteria Mycobacterium tuberculosis. It is a major public health concern in many countries around the world, and the World Health Organization estimates that around 10 million people are infected with the disease each year. The most common form of TB is pulmonary TB, which affects the lungs. Chest radiographs are a common tool for diagnosing and monitoring pulmonary TB, as they allow for the visualization of the lungs and any associated abnormalities. Although chest radiographs are widely used in TB care, there are both benefits and drawbacks associated with their use.

Benefits of Chest Radiographs in TB Care

The primary benefit of chest radiographs in TB care is their ability to visualize the lungs and associated abnormalities. Chest radiographs are quick and non-invasive, requiring only a few minutes to take and interpret. They can be used to detect areas of consolidation or cavitation, which are common in pulmonary TB. They can also detect other abnormalities such as pleural effusions or pleural thickening, which may be associated with TB. Chest radiographs are also useful for follow-up of TB patients to assess for disease progression or treatment response.

Chest radiographs are also relatively inexpensive and widely available, making them a convenient tool for TB care in many settings. They do not require the use of laboratory equipment or specialized personnel, and can be performed in most clinics or hospitals. In addition, chest radiographs can be used to differentiate TB from other respiratory diseases, such as pneumonia or bronchitis. This can be especially useful in settings where access to laboratory tests or other imaging modalities is limited.

Drawbacks of Chest Radiographs in TB Care

One of the primary drawbacks of chest radiographs in TB care is their limited sensitivity. Chest radiographs are not always able to detect small lesions or nodules, and may miss early stages of disease. In addition, chest radiographs are not always able to differentiate between active and inactive TB lesions. This can lead to misdiagnosis or delayed diagnosis, which may have serious consequences for the patient.

Chest radiographs are also limited in their ability to detect extra pulmonary TB. This type of TB is more difficult to diagnose, as it is not visible on chest radiographs. Other imaging modalities such as computed tomography (CT) or MRI may be more useful for detecting extra pulmonary TB.

Finally, chest radiographs are not without their risks. In particular, radiation exposure is a concern, as radiographs may expose patients to higher levels of radiation than other imaging modalities. There is also a risk of incorrect interpretation, as radiographs must be read by a skilled radiologist.

Conclusion

Overall, chest radiographs are a useful tool for diagnosing and monitoring pulmonary TB. They are quick, non-invasive, and widely available, making them a convenient tool for TB care in many settings. However, chest radiographs have several drawbacks, including limited sensitivity, inability to detect extra pulmonary TB, and risks associated with radiation exposure. Therefore, chest radiographs should be used in combination with other imaging modalities and laboratory tests when possible.

References

1. World Health Organization, Global Tuberculosis Report 2019. Accessed October 14, 2020. https://www.who.int/tb/publications/global_report/en/

2. Centers for Disease Control and Prevention. Tuberculosis (TB). Accessed October 14, 2020. https://www.cdc.gov/tb/

3. World Health Organization. Diagnosis of Tuberculosis. Accessed October 14, 2020. https://www.who.int/tb/publications/tb_diagnosis/en/

4. American Thoracic Society. Imaging of Tuberculosis. Accessed October 14, 2020. https://www.thoracic.org/patients/patient-resources/resources/imaging-tuberculosis.pdf

5. Bae JM, Tison GH, Iseman MD. Radiographic findings in patients with pulmonary tuberculosis before and after treatment. Chest. 2000;117(2):405-411. doi:10.1378/chest.117.2.405